Markets

Sakar Healthcare Reports Q1 FY27 Results: Revenue Rises 38% as Oncology Focus Drives Profitability Sakar Healthcare Limited has released its un-audited financial results for the first quarter of FY27, reporting significant growth in revenue and profitability driven by its expanding oncology portfolio and commitment to vertical integration. The company saw a marked increase in operating margins and is solidifying its transition toward an integrated, regulatory-driven business model.Financial Highlights (Q1 FY27) The financial performance for the quarter reflected strong execution across various segments. Revenue from operations reached ₹ 7,297.25 lakhs, marking a 38% year-on-year (YoY) growth. EBITDA increased by 67% YoY to ₹ 2,124.89...

Suzlon Posts Strong Q1 FY27 Results, Pushing Revenue Up 23% and Reaching Highest Ever Deliveries Pune, India — Suzlon Energy Limited reported robust consolidated financial results for the first quarter of fiscal year 2027 (Q1 FY27), announcing a 23% year-on-year increase in revenue. The company also highlighted achieving its highest ever Q1 deliveries milestone.The Board of Directors approved the unaudited limited reviewed financial results on standalone and consolidated basis for the quarter ended June 30, 2026. Management introduced the "Suzlon 2.0" strategy, focusing on four strategic growth engines: RE Technology, RE Development Company (DevCo), RE Projects, and RE Asset Management Services (AMS).Financial Performance Highlights...

LIC Appoints Key Management Personnel: Varadarajan Muthuvenkataraman as Chief Risk Officer and Shatmanyu Shrivastava as CFO The Board of Directors of the Life Insurance Corporation of India (LIC) approved significant changes in its Key Managerial Personnel (KMP) on July 28, 2026. The appointments, made based on recommendations from the Nomination & Remuneration Committee, include Shri Varadarajan Muthuvenkataraman as Executive Director (Enterprise Risk Management) & Chief Risk Officer and Shri Shatmanyu Shrivastava as Executive Director (Finance & Accounts) & Chief Financial Officer.The leadership changes involve both internal re-designations and new appointments for critical executive roles within the Corporation. The appointed...

Himatsingka Seide Limited Allots Rs 12.75 Crore in Private Placement of Tranche 2 Series E Non-Convertible Debentures Himatsingka Seide Limited announced the successful allotment of Tranche 2 Series E Unlisted, Senior, Secured, Unrated, Redeemable, Taxable Transferable Non-Convertible Debentures (NCDs). The allotment took place on July 28, 2026.The company allotted a total of 255 Tranche 2 Series E Debentures, each having a face value of Rs 5,00,000/-. This issuance aggregated to Rs 12,75,00,000/-, which was raised through a private placement basis.The NCDs are denominated in Indian Rupees and feature several key protective features, including being senior, secured, unrated, and taxable. The tenure of the instrument is set at 42...

IndiGo Achieves Operational Milestones While Reporting Significant Green Emission Intensity Reduction IndiGo Aviation Limited, a prominent player in the aviation sector, has reported substantial growth alongside major strides in sustainability and operational efficiency for the financial year 2025-26. The airline expanded its fleet capacity, introduced next-generation aircraft, and significantly enhanced its commitment to decarbonization, achieving an 18.9% reduction in GHG emission intensity per Available Seat Kilometer (ASK).The report details that IndiGo’s fleet grew to 441 aircraft during the reporting period. In a key move for international expansion, the airline became one of the first Indian carriers to induct the Airbus...

Century Enka Reports Q1 FY27 Results; Consolidated Revenue Reaches 56,278 Lacs Century Enka Limited released its unaudited financial results for the quarter ended June 30, 2026. The results detail performance across both standalone and consolidated segments, with the company stating that these figures were reviewed and approved by the Board of Directors at a meeting held on July 28, 2026.The Statement highlights the company’s business activity within a single operating segment: "Synthetic Yarn."Financial Performance Snapshot (Consolidated) The consolidated results for the three months ended June 30, 2026, show the following key financial movements:ParticularsThree Months Ended 30-Jun-26Three Months Ended 31-Mar-26Three Months...

Indian Railways Boosts Capacity: ₹163 Cr Traction Upgrade Signals Major Leap for High-Density Corridors Indian Railways has sanctioned a significant infrastructure investment aimed at strengthening network capacity and modernizing operational efficiency across key rail corridors. The project involves upgrading the electric traction system on the Parbhani-Mudkhed double line section within the Nanded Division of South Central Railway. This critical upgrade, valued at Rs. 163 crore, includes necessary associated power supply installation works.Transforming Rail Infrastructure in South Central Railway The modernization effort focuses on transforming the existing electrical infrastructure to handle increasing operational demands. The...

SEBI Suspend Risk Easing for Commodity Derivatives as Global Instability Forces Full Review Markets regulator Securities and Exchange Board of India (SEBI) has placed a key risk management reform concerning commodity derivatives on hold. Although the public consultation on the proposal was completed, sources indicate that SEBI decided to keep the plan in abeyance temporarily. This decision follows an overall review mandate for the risk management framework within the volatile commodity segment.SEBI issued a note to exchanges and clearing corporations stating that the proposal is paused. The regulator cited heightened uncertainty across global commodity markets as a primary reason for the deferral of the change. This caution comes amid...

Deep Industries Limited Releases Q1 FY27 Financial Results Announces Key Appointments and ESOP Scheme Deep Industries Limited (DIL) has released its unaudited financial results for the quarter ended June 30, 2026, alongside updates regarding executive appointments, a new employee stock option scheme, and leadership changes within the company. The Board of Directors approved these matters during a meeting held on July 28, 2026.The company also set August 21, 2026, as the Record Date for determining eligibility for the Final Dividend pertaining to the Financial Year 2025-26.Quarterly Financial Performance Review DIL provided both standalone and consolidated unaudited financial results for the quarter ending June 30, 2026. The...

ESGRisk.ai Assigns ESG Rating of 86 to Tech Mahindra Limited ESG Risk Assessments and Insights Limited (ESGRisk.ai), a SEBI registered Category I Subscriber-Pays rating provider, has assigned an ESG rating of 86 to Tech Mahindra Limited. The rating was independently prepared and voluntarily issued by ESGRisk.ai based on the company's disclosures for fiscal 2026 and other publicly available data.The assignment comes after the communication from ESGRisk.ai was received by Tech Mahindra Limited on Monday, July 27, 2026, at 6:28 p.m. (IST). A key aspect of this rating is that Tech Mahindra has not engaged ESGRisk.ai for the ESG Rating process; rather, the assessment was conducted independently by the specialized firm.The findings and...

Silky Overseas Limited Secures Board Approval for ₹1.32 Crore Term Loan to Finance Solar Projects Silky Overseas Limited has received board approval to avail a significant Term Loan Facility from the Bank of Baroda SME Branch in New Delhi. The loan is designated for financing solar projects and amounts to ₹1,32,00,000 (Rupees One Crore and Thirty-Two Lakh Only).The decision was taken during the Board of Directors meeting held on July 28, 2026. Following the approval by the company's board, Silky Overseas Limited is set to finalize the terms and conditions of the facility with Bank of Baroda.In addition to approving the loan, the Board granted specific authorization regarding the necessary financial obligations. Directors Mr. Sawar...

Coal India Limited Q1 Results Show Financial Performance Across Comparison Periods Coal India Limited has released its unaudited financial results for the first quarter ended June 30, 2026, showing performance across both consolidated and standalone segments compared to previous periods.The company's performance metrics provide insights into operational income and profitability during the quarter ending June 30, 2026.Consolidated Financial Highlights In the consolidated segment, Total Income from Operations stood at 46254.80 for the first quarter ended June 30, 2026. The Net Profit/(Loss) for the period (before tax, exceptional and/or extraordinary items) recorded was 11719.36. After tax, the Net Profit/ (Loss) for the period was...

Coal India Limited Capex Jumps 16.64% in Q1 FY'27, Exceeds Quarterly Target Kolkata, July 28, 2026: Coal India Limited (CIL) reported a robust capital expenditure (capex) of ₹3,399 crore for the first quarter (Q1) of Financial Year 2026-27. This represents significant growth, standing at 16.64% higher than the ₹2,914 crore spent during the corresponding period of the previous fiscal year. The company successfully surpassed its Q1 capex goal, achieving 101.5% of the planned expenditure. CIL's spending in this quarter accounted for 20.60% of its total capital expenditure target set at ₹16,500 crore for the current fiscal year.The Q1 investments were strategically distributed across several major areas, with expenditures on land...

ZF CVCS India Secures ESC Business Nominations from Three OEMs for Domestic Truck Safety Mandate ZF Commercial Vehicle Control Systems India Limited has secured business nominations from three leading Indian commercial vehicle Original Equipment Manufacturers (OEMs). The contracts pertain to multi-year domestic programs, solidifying the company's role as India prepares for new safety standards in the trucking industry.The nominations cover the provision of Electronic Stability Control (ESC) solutions across 24V and 12V truck platforms. These systems are designed to support upcoming vehicle programs that are required to meet India's mandatory ESC safety regulations, with production scheduled to commence in the third quarter of 2027...

Nifty IT Surges Past Chip Stocks as Investors Exit AI Hype for Deeper Rebound Indian IT Sector Leads Global Market Rally Over Semiconductor Downturn The NSE Nifty IT Index has delivered a significant performance this month, showing investor appetite is shifting away from the high-flying artificial intelligence (AI) trade. The index, which tracks 10 leading Indian software exporters, recorded an impressive 16% jump during the period. This strong performance highlights renewed interest in India's established technology services firms following a protracted slump.In contrast, global semiconductor and allied equipment makers are seeing declines. MSCI Inc.'s measure covering these sectors has slipped by 13%. This notable divergence between...

Dhunseri Investments Limited announces 29th AGM and makes FY 2025-26 Annual Report available Dhunseri Investments Limited has scheduled its 29th Annual General Meeting (AGM) for the members. The company has also made the Annual Report for Fiscal Year 2025-26 available to all shareholders, along with the Notice of the AGM.The 29th AGM is set to be held on Thursday, August 20, 2026, at 11:30 A.M. (IST). The meeting will be conducted through Video Conferencing or other Audio Visual Means.The Annual Report for FY 2025-26, which includes the Notice of the AGM, has been made available electronically. Shareholders can access the complete details by visiting the company's website at...

Teja Engineering Industries Reports Standalone Financial Results for Half Year Ending March 31, 2026 Teja Engineering Industries Limited has released its audited standalone financial results for the half-year ended March 31, 2026. The company is engaged primarily in services related to Testing, Calibration, and O&M. The results provide insight into the operational performance of the company across various metrics.Financial Performance Highlights (Half Year Ended 31/03/2026) The financial statements show a summary of operations for the half-year period ending March 31, 2026, compared to prior periods. Key figures from the income statement are as follows:ParticularsHalf Year Ended 31/03/2026Half Year Ended 30/09/2025Half Year Ended...

AstraZeneca Gains Permission to Import Enhertu for Neoadjuvant Breast Cancer Treatment in India AstraZeneca Pharma India Limited has received authorization from the Central Drugs Standard Control Organization, Directorate General of Health Services, Government of India, allowing it to import and distribute Trastuzumab Deruxtecan 100mg/5mL lyophilized powder for concentrate for solution for infusion (Brand name: Enhertu®) for an additional indication.The permission was granted on July 27, 2026. This approval paves the way for marketing Enhertu® in India for a specific new use case.Under this authorization, Trastuzumab deruxtecan is indicated for the neoadjuvant treatment of adult patients with HER2-positive (IHC 3+ or ISH+) Stage II...

Chip Stocks Plunge as AI Anxiety Hits Tech Giants Amid Competition Fears Global Market Turmoil: Tech Indices Suffer Heavy Selloff Global chip stocks experienced a severe downturn across Asian markets on July 28. The tech rout was fueled by mounting concerns over Chinese competition and uncertainty regarding who will ultimately fund the massive global artificial intelligence (AI) boom. This sharp decline occurred as investors digested worries about potential US rate hikes expected to begin this week.South Korea's KOSPI plunged nearly 10%, hitting a three-month low. The index triggered a circuit breaker during the downward slide, marking a major reversal from its previous performance. Notably, KOSPI had more than tripled over the past...

Alembic Pharmaceuticals Secures USFDA Final Approval for Prucalopride Tablets Alembic Pharmaceuticals Limited announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) covering Prucalopride Tablets, 1 mg and 2 mg.The approved ANDA signifies that Alembic's product is therapeutically equivalent to Motegrity Tablets, 1 mg and 2 mg, manufactured by Takeda Pharmaceuticals USA Inc. Prucalopride tablets are indicated as a serotonin-4 receptor agonist used in the treatment of chronic idiopathic constipation (CIC) in adults.The market potential for Prucalopride Tablets, 1 mg and 2 mg is estimated at US$ 100 million for twelve months ending March 2026...